These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10418992)

  • 1. Progestins in the menopause.
    Sitruk-Ware R
    J Steroid Biochem Mol Biol; 1999; 69(1-6):185-93. PubMed ID: 10418992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestogens in hormonal replacement therapy: new molecules, risks, and benefits.
    Sitruk-Ware R
    Menopause; 2002; 9(1):6-15. PubMed ID: 11791081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rationale for a wider range of progestogens.
    Skouby SO
    Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.
    Pike MC; Ross RK
    Steroids; 2000; 65(10-11):659-64. PubMed ID: 11108873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestin replacement in the menopause: effects on the endometrium and serum lipids.
    Williams DB; Moley KH
    Curr Opin Obstet Gynecol; 1994 Jun; 6(3):284-92. PubMed ID: 8038417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adverse effects of hormonal therapy.
    Bush TL
    Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of progestins in different hormone replacement therapy formulations on estrogen-induced lipid changes in postmenopausal women.
    Shulman LP
    Am J Cardiol; 2002 Jun; 89(12A):47E-54E; discussion 54E-55E. PubMed ID: 12084405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New progestogens: a review of their effects in perimenopausal and postmenopausal women.
    Sitruk-Ware R
    Drugs Aging; 2004; 21(13):865-83. PubMed ID: 15493951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the cardiovascular and breast actions of drospirenone in preclinical studies.
    Simoncini T; Genazzani AR
    Climacteric; 2010 Feb; 13(1):22-33. PubMed ID: 19938948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical use of progestins in the menopausal patient: dosage and duration.
    Gambrell RD
    J Reprod Med; 1982 Aug; 27(8 Suppl):531-8. PubMed ID: 7131446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous progestagens and the human breast.
    Sitruk-Ware R; Plu-Bureau G
    Maturitas; 2004 Sep; 49(1):58-66. PubMed ID: 15351097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Olsson HL; Ingvar C; Bladström A
    Cancer; 2003 Mar; 97(6):1387-92. PubMed ID: 12627501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestins in HRT: sufferance or desire?
    Skouby SO; Jespersen J
    Maturitas; 2009 Apr; 62(4):371-5. PubMed ID: 19203850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestins and cancer.
    Sitruk-Ware R; Plu-Bureau G
    Gynecol Endocrinol; 1999 Jun; 13 Suppl 4():3-9. PubMed ID: 12227896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How progestins influence the cardiovascular effect of hormone replacement therapy.
    Rosano GM; Mercuro G; Vitale C; Rossini P; Galetta P; Fini M
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():9-17. PubMed ID: 12227881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.